From mouse fashions to freshly remoted human nerves, researchers traced what occurs when chemotherapy disrupts the mobile equipment that delivers power to susceptible sensory axons.
Examine: Psilocybin prevents chemotherapy-induced peripheral neuropathy through mitochondrial trafficking preservation. Picture Credit score: YARphotographer / Shutterstock
In a latest examine revealed within the journal Science, researchers investigated the preclinical results of the prophylactic administration of the serotonergic psychedelic psilocybin on the event of chemotherapy-induced peripheral neuropathy (CIPN).
The examine used preclinical C57BL/6J mice and human cell and nerve tissue fashions to guage the results of the remedy on behavioral sensory metrics, electrophysiology, dwell mitochondrial trafficking, and human nerve tissue, with a deal with the 5-HT2A receptor.
Examine findings demonstrated that two psilocybin pretreatments had been adequate to stop mechanical hypersensitivity in an preliminary cisplatin mannequin, whereas cycle-matched psilocybin pretreatment maintained safety in opposition to mechanical hypersensitivity throughout six month-to-month chemotherapy cycles and greater than 8 months of follow-up, with out measurably impairing antitumor efficacy in tumor-bearing mice.
The examine additionally discovered that the non-hallucinogenic 5-HT2A agonist TBG supplied comparable safety in opposition to mechanical hypersensitivity in mice, indicating that hallucinogenic exercise will not be required for this neuroprotective impact and that non-hallucinogenic 5-HT2A agonists warrant additional examine.
Background
Chemotherapy-induced peripheral neuropathy (CIPN) is a typical, disabling facet impact of most cancers chemotherapy that may have an effect on as much as 60% of sufferers receiving some neurotoxic regimens. The situation outcomes from neurotoxic chemotherapeutic brokers (e.g., cisplatin, paclitaxel, and docetaxel) damaging the peripheral nerves, resulting in progressively worsening signs starting from numbness and tingling to extreme ache, usually affecting the sufferers’ fingers and toes.
Regardless of intensive analysis aimed toward mitigating the situation, CIPN is noticed to be usually irreversible, typically forcing clinicians to cut back sufferers’ chemotherapy doses or prematurely terminate the remedy cycles. Prior analysis has linked CIPN to distal sensory axonopathy, marked intraepidermal nerve fiber (IENF) loss within the pores and skin, and maladaptive reorganization of cortical ache processing.
Moreover, earlier biochemical and oncological research have discovered that, on the mobile degree, platinum- and taxane-based chemotherapeutic brokers induce extreme mitochondrial dysfunction, through which lively axonal transport of mitochondria is arrested, thereby ravenous distal terminals of adenosine 5′-triphosphate (ATP).
Sadly, hitherto, no preventive therapies for CIPN have been permitted, proscribing present interventions to symptomatic administration.
In regards to the examine
The current examine aimed to deal with these persistent therapeutic limitations and inform future CIPN analysis and interventions by investigating whether or not pre-chemotherapy publicity to psilocybin might assist forestall or scale back peripheral neurotoxicity.
The examine used C57BL/6J mice in cisplatin, paclitaxel, and docetaxel fashions, together with a six-cycle cisplatin routine designed to mannequin repeated chemotherapy publicity. Moreover, cisplatin was examined in a syngeneic oral most cancers (MOC1) mannequin pretreated with psilocybin.
The examine first evaluated sensorimotor conduct utilizing von Frey testing, acetone chilly allodynia, adhesive tape elimination, and nesting assays. Subsequent, electrophysiological community dynamics had been assessed utilizing whole-cell patch-clamp of dorsal root ganglion (DRG) neurons, medial prefrontal cortex (mPFC) microelectrode arrays, and steady electroencephalography (EEG).
The researchers additionally tracked mitochondrial motion inside axons and molecular signaling utilizing live-cell mitochondrial kymography, transmission electron microscopy, reverse-phase protein arrays (RPPA), and RNA sequencing and transcriptomic profiling.
The translational relevance of the preclinical findings was examined utilizing human stem cell-derived sensory neurons (iSNs), organ donor DRGs, and freshly harvested peripheral nerves from 29 surgical sufferers.
Examine findings
The examine’s analyses revealed that two prophylactic doses of psilocybin utterly prevented cisplatin-induced mechanical hypersensitivity within the preliminary mannequin, whereas cycle-matched pretreatment maintained safety in opposition to mechanical hypersensitivity throughout six repeated remedy cycles. Psilocybin additionally attenuated cisplatin-induced chilly allodynia, preserved tactile acuity, and maintained cutaneous IENF density.
In preclinical murine fashions, psilocybin retained neuroprotective results with out measurable modifications in tumor development or systemic cytokine profiles in tumor-bearing mice, suggesting that neuroprotection didn’t measurably have an effect on these endpoints on this mannequin. Pharmacological evaluations confirmed that this neuroprotection was 5-HT2A receptor-dependent, as selective antagonism with volinanserin utterly abolished psilocybin’s safety in opposition to mechanical hypersensitivity.
Most notably, the examine revealed that the non-hallucinogenic agonist TBG conferred safety in opposition to mechanical hypersensitivity akin to that of psilocybin, supporting the conclusion that hallucinogenic exercise just isn’t required for this neuroprotective impact.
The examine’s mechanistic investigations recognized a dual-site mechanism whereby, centrally, psilocybin restored mPFC community exercise, considerably maintained beta-band EEG energy, confirmed an identical development in alpha energy, and prevented sigma-band suppression, in line with safety in opposition to chemotherapy-induced central community dysfunction, whereas peripherally, psilocybin was discovered to take care of native axonal power distribution with out suppressing acute DRG nociceptor hyperexcitability.
Lastly, live-cell imaging in human peripheral nerves confirmed that cisplatin markedly impaired mitochondrial motility, whereas psilocybin maintained mitochondrial trafficking and transport velocity. Molecular and pharmacological experiments implicated 5-HT2A-dependent activation of the TrkB-Akt-PAK5-MAP2-KIF5B pathway, along with remobilization of syntaphilin-anchored mitochondria, in preserving mitochondrial distribution and native ATP provide inside distal axons.
Conclusions
The current examine supplies preclinical proof that prophylactic psilocybin might forestall or scale back CIPN, with ex vivo human nerve experiments exhibiting that psilocybin maintained mitochondrial trafficking and transport velocity, which had been in any other case impaired by cisplatin.
The examine additional demonstrated that the non-hallucinogenic 5-HT2A agonist TBG reproduced safety in opposition to mechanical hypersensitivity in mice, suggesting that hallucinogenic exercise will not be obligatory for no less than this facet of neuroprotection. Nonetheless, neither psilocybin nor TBG was examined clinically for CIPN prevention. Transferring ahead, cycle-aligned 5-HT2A agonism represents a candidate prophylactic technique that warrants medical analysis, together with evaluation of whether or not neuroprotection may be achieved with out compromising antitumor remedy.
